| Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation P Viatour, MP Merville, V Bours, A Chariot Trends in biochemical sciences 30 (1), 43-52, 2005 | 1830 | 2005 |
| The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers V Bours, G Franzoso, V Azarenko, S Park, T Kanno, K Brown, U Siebenlist Cell 72 (5), 729-739, 1993 | 695 | 1993 |
| NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells M Bentires-Alj, V Barbu, M Fillet, A Chariot, B Relic, N Jacobs, J Gielen, ... Oncogene 22 (1), 90-97, 2003 | 654 | 2003 |
| RelB, a new Rel family transcription activator that can interact with p50-NF-κB RP Ryseck, P Bull, M Takamiya, V Bours, U Siebenlist, P Dobrzanski, ... Molecular and cellular biology 12 (2), 674-684, 1992 | 488 | 1992 |
| The candidate oncoprotein Bcl-3 is an antagonist of pSO/NF-κB-mediated inhibition G Franzoso, V Bours, S Park, M Tomfta-Yamaguchi, K Kelly, U Siebenlist Nature 359 (6393), 339-342, 1992 | 437 | 1992 |
| Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study AF Daly, MA Tichomirowa, P Petrossians, E Heliovaara, ML Jaffrain-Rea, ... The Journal of Clinical Endocrinology & Metabolism 95 (11), E373-E383, 2010 | 416 | 2010 |
| Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families AF Daly, JF Vanbellinghen, SK Khoo, ML Jaffrain-Rea, LA Naves, ... The Journal of Clinical Endocrinology & Metabolism 92 (5), 1891-1896, 2007 | 376 | 2007 |
| Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs V Bours, J Villalobos, PR Burd, K Kelly, U Siebenlist Nature 348 (6296), 76-80, 1990 | 374 | 1990 |
| A novel mitogen-inducible gene product related to p50/pl05-NF-κB participates in transactivation through a κB site V Bours, PR Burd, K Brown, J Villalobos, S Park, RP Ryseck, R Bravo, ... Molecular and cellular biology 12 (2), 685-695, 1992 | 360 | 1992 |
| Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation G Trivellin, AF Daly, FR Faucz, B Yuan, L Rostomyan, DO Larco, ... New England Journal of Medicine 371 (25), 2363-2374, 2014 | 357 | 2014 |
| Nuclear factor-κB, cancer, and apoptosis V Bours, M Bentires-Alj, AC Hellin, P Viatour, P Robe, S Delhalle, ... Biochemical pharmacology 60 (8), 1085-1089, 2000 | 336 | 2000 |
| Reactive oxygen intermediate-dependent NF-κB activation by interleukin-1β requires 5-lipoxygenase or NADPH oxidase activity G Bonizzi, J Piette, S Schoonbroodt, R Greimers, L Havard, MP Merville, ... Molecular and cellular biology 19 (3), 1950-1960, 1999 | 288 | 1999 |
| Multiple redox regulation in NF-kappaB transcription factor activation. J Piette, B Piret, G Bonizzi, S Schoonbroodt, MP Merville, ... Biological chemistry 378 (11), 1237-1245, 1997 | 269 | 1997 |
| The NF-κB transcription factor and cancer: high expression of NF-κB-and IκB-related proteins in tumor cell lines V Bours, E Dejardin, F Goujon-Letawe, MP Merville, V Castronovo Biochemical pharmacology 47 (1), 145-149, 1994 | 266 | 1994 |
| The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. G Franzoso, V Bours, V Azarenko, S Park, M Tomita‐Yamaguchi, T Kanno, ... The EMBO journal 12 (10), 3893-3901, 1993 | 252 | 1993 |
| Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia P Close, N Hawkes, I Cornez, C Creppe, CA Lambert, B Rogister, ... Molecular cell 22 (4), 521-531, 2006 | 246 | 2006 |
| NF-κB2/p100 induces Bcl-2 expression P Viatour, M Bentires-Alj, A Chariot, V Deregowski, L de Leval, ... Leukemia 17 (7), 1349-1356, 2003 | 238 | 2003 |
| The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and … CA Stratakis, MA Tichomirowa, S Boikos, MF Azevedo, M Lodish, ... Clinical genetics 78 (5), 457-463, 2010 | 228 | 2010 |
| An insertion–deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases V Dideberg, G Kristjansdottir, L Milani, C Libioulle, S Sigurdsson, E Louis, ... Human molecular genetics 16 (24), 3008-3016, 2007 | 227 | 2007 |
| Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients L Rostomyan, AF Daly, P Petrossians, E Nachev, AR Lila, AL Lecoq, ... Endocrine-related cancer 22 (5), 745-757, 2015 | 206 | 2015 |
